Articles

Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in adults and is a slowly progressing cancer of the blood and bone marrow. According to cancer statistics, an estimated 16,060 new CLL diagnoses will be made in the United States in 2012. Read More ›

Since the approval of bendamustine, healthcare practitioners have additional treatment options available to patients with specific hematologic malignancies. In the United States, bendamustine was approved for patients with chronic lymphocytic leukemia (CLL) or indolent B-cell non-Hodgkin lymphoma (NHL) who had progressed within 6 months of receiving rituximab-containing regimens. Read More ›

A small percentage of men in a recent study complained that their penis seemed shorter following prostate cancer treatment. Read More ›

A large percentage of male cancer patients are not receiving appropriate fertility advice. Read More ›

In the quest to prevent colon cancer, researchers developed a vaccine that effectively stimulated the immune system to respond to early indications of colon cancer in patients at high risk for the disease. Read More ›

Researchers recently released comprehensive retrospective study results comparing the major types of prostate cancer treatments in terms of saving lives and cost-effectiveness. Read More ›

Overall cancer death rates continued to decline in the United States among both men and women. Read More ›

A national drug shortage of mechlorethamine has been linked to a higher rate of relapse among children, teenagers, and young adults with Hodgkin lymphoma enrolled in a national clinical trial. Read More ›

When determining how well tamoxifen works, new study results provide evidence that genetic differences in the enzyme CYP2D6 play a key role. Read More ›

Researchers recently assessed the widespread implementation of CT scanning for the early detection of lung cancer in a public health setting. Read More ›